Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

被引:1103
|
作者
Lipinski, Christopher A. [1 ]
Lombardo, Franco [1 ]
Dominy, Beryl W. [1 ]
Feeney, Paul J. [1 ]
机构
[1] Pfizer Inc, Div Cent Res, Groton, CT 06340 USA
关键词
Rule of 5; Computational alert; Poor absorption or permeation; MWT; MLogP; H-Bond donors and acceptors; Turbidimetric solubility; Thermodynamic solubility; Solubility calculation; WATER PARTITION-COEFFICIENTS; AQUEOUS SOLUBILITY; ORGANIC-COMPOUNDS; THEORETICAL DESCRIPTORS; MELTING-POINT; OCTANOL; PARAMETER; CONSTRUCTION; ABSORPTION; PREDICTION;
D O I
10.1016/j.addr.2012.09.019
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Experimental and computational approaches to estimate solubility and permeability in discovery and development settings are described. In the discovery setting 'the rule of 5' predicts that poor absorption or permeation is more likely when there are more than 5 H-bond donors, 10 H-bond acceptors, the molecular weight (MWT) is greater than 500 and the calculated Log P (CLogP) is greater than 5 (or MlogP>4.15). Computational methodology for the rule-based Moriguchi Log P (MLogP) calculation is described. Turbidimetric solubility measurement is described and applied to known drugs. High throughput screening (FITS) leads tend to have higher MWT and Log P and lower turbidimetric solubility than leads in the pre-HTS era. In the development setting, solubility calculations focus on exact value prediction and are difficult because of polymorphism. Recent work on linear free energy relationships and Log P approaches are critically reviewed. Useful predictions are possible in closely related analog series when coupled with experimental thermodynamic solubility measurements. (C) 2012 Published by Elsevier B.V.
引用
收藏
页码:4 / 17
页数:14
相关论文
共 50 条
  • [41] Modern Computational Approaches in Drug Discovery: A State of the Art Technology
    Singh, Sanjeev Kumar
    CURRENT COMPUTER-AIDED DRUG DESIGN, 2021, 17 (07) : 849 - 849
  • [42] Current Status of Computational Approaches for Small Molecule Drug Discovery
    Xu, Weijun
    JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (21) : 18633 - 18636
  • [43] Computational Approaches: Drug Discovery and Design in Medicinal Chemistry and Bioinformatics
    Tutone, Marco
    Almerico, Anna Maria
    MOLECULES, 2021, 26 (24):
  • [44] Theoretical and computational approaches to ligand-based drug discovery
    Favia, Angelo D.
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2011, 16 : 1276 - 1290
  • [45] DRUG DISCOVERY AND DEVELOPMENT APPROACHES FOR THE TREATMENT OF HELMINTHIASIS
    Hawryluk, Natalie A.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2019, 101 : 352 - 352
  • [46] Editorial: Innovative approaches in drug discovery and development
    Ramadan, Qasem
    Perinelli, Diego Romano
    Orian, Laura
    Baratchi, Sara
    FRONTIERS IN MEDICAL TECHNOLOGY, 2023, 5
  • [47] Natural Products in Drug Discovery: Approaches and Development
    Tresina, Pious Sons
    Selvam, Murugeswaran Santhiya
    Rajesh, Authinarayanan
    Doss, Asirvatham
    Mohan, Veerabahu Ramasamy
    JOURNAL OF PHARMACEUTICAL RESEARCH INTERNATIONAL, 2021, 33 (35A) : 93 - 110
  • [48] Experimental and computational screening models for prediction of aqueous drug solubility
    Bergström, CAS
    Norinder, U
    Luthman, K
    Artursson, P
    PHARMACEUTICAL RESEARCH, 2002, 19 (02) : 182 - 188
  • [49] Experimental and Computational Screening Models for Prediction of Aqueous Drug Solubility
    Christel A. S. Bergström
    Ulf Norinder
    Kristina Luthman
    Per Artursson
    Pharmaceutical Research, 2002, 19 : 182 - 188
  • [50] Agonist antibody discovery: Experimental, computational, and rational engineering approaches
    Schardt, John S.
    Jhajj, Harkamal S.
    O'Meara, Ryen L.
    Lwo, Timon S.
    Smith, Matthew D.
    Tessier, Peter M.
    DRUG DISCOVERY TODAY, 2022, 27 (01) : 31 - 48